SPM962

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	6

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 6 of 6 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-000827-15-IT (EUCTR)	11/05/2013	15/03/2013	LATE ONSET PARKINSON’S DISEASE IN SUBJECTS 70 YEARS AND OLDER: POSSIBLE USE OF ROTIGOTINE	LATE ONSET PARKINSON’S DISEASE IN SUBJECTS 70 YEARS AND OLDER: POSSIBLE USE OF ROTIGOTINE - PARROT	Parkinson disease;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: Rotigotine Product Name: neurpro Product Code: SPM962	Unità Malattie Neurodegenerative, Ospedale Cardinale Giovanni Panico, Tricase	NULL	Not Recruiting			Female: yes Male: yes			Italy
2	NCT01631825 (ClinicalTrials.gov)	October 2009	25/6/2012	A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients	An Open-label Long-term Extension Trial From Phase III of SPM962(243-08-002) in Advanced Parkinson's ...	Parkinson's Disease	Drug: SPM 962	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	N/A	N/A	All	321	Phase 3	Japan
3	NCT01628965 (ClinicalTrials.gov)	January 2008	25/6/2012	A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients	An Open-label Long-term Extension Trial From Phase II/III of SPM962(243-07-001) in Early Parkinson's ...	Parkinson's Disease	Drug: SPM 962	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	N/A	N/A	All	143	Phase 2/Phase 3	Japan
4	NCT01631812 (ClinicalTrials.gov)	December 2006	25/6/2012	A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients	An Open-label Long-term Extension Trial From Late Phase II of SPM962(243-05-001) in Advanced Parkins ...	Parkinson's Disease	Drug: SPM 962	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	N/A	N/A	All	130	Phase 2	Japan
5	EUCTR2004-002609-66-DE (EUCTR)	06/12/2004	22/04/2005	A phase 3, randomized, open-label, two-arm, parallel-group, multicenter, multinational trial to comp ...	A phase 3, randomized, open-label, two-arm, parallel-group, multicenter, multinational trial to comp ...	Parkinson's Disease	Product Name: Rotigotine Product Code: SPM962 INN or Proposed INN: Rotigotine Product Name: Rotigotine P ...	Schwarz Biosciences GmbH	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 3	Germany;Italy
6	EUCTR2004-000148-26-IT (EUCTR)	14/06/2004	26/07/2007	A multi-center, multinational, phase 3, open-label extension trial to assess the safety of long term ...	A multi-center, multinational, phase 3, open-label extension trial to assess the safety of long term ...	Advanced stage Parkinson's Disease	INN or Proposed INN: rotigotine	SCHWARZ PHARMA	NULL	Not Recruiting			Female: yes Male: yes	360	Phase 3	Hungary;Finland;Czech Republic;Spain;Italy;Sweden

First Previous1Next Last